164 related articles for article (PubMed ID: 23480749)
21. Role of CD15 expression in dysplastic and neoplastic tissue of the bile duct - a potential novel tool for differential diagnosis of indeterminate biliary stricture.
Walter D; Herrmann E; Winkelmann R; Albert JG; Liese J; Schnitzbauer A; Zeuzem S; Hansmann ML; Peveling-Oberhag J; Hartmann S
Histopathology; 2016 Dec; 69(6):962-970. PubMed ID: 27442966
[TBL] [Abstract][Full Text] [Related]
22. Transpapillary biliary biopsy for malignant biliary strictures: comparison between cholangiocarcinoma and pancreatic cancer.
Chen WM; Wei KL; Chen YS; Chang PJ; Tung SY; Chang TS; Huang HC; Shen CH; Hsieh YY; Wu CS
World J Surg Oncol; 2016 May; 14():140. PubMed ID: 27142076
[TBL] [Abstract][Full Text] [Related]
23. Clinical presentation, diagnosis, and survival in cholangiocarcinoma: A prospective study.
Vasilieva L; Papadhimitriou SI; Alexopoulou A; Kostopoulos I; Papiris K; Pavlidis D; Xinopoulos D; Romanos A; Dourakis SP
Arab J Gastroenterol; 2016 Dec; 17(4):181-184. PubMed ID: 27914884
[TBL] [Abstract][Full Text] [Related]
24. A mixed hepatocellular carcinoma and cholangiocarcinoma: dual expression of biliary-type cytokeratin and hepatocyte specific marker.
Tanaka S; Hirohashi K; Uenishi T; Yamamoto T; Hamba H; Kubo S; Tanaka H; Shuto T; Ogawa M; Kinoshita H
Hepatogastroenterology; 2004; 51(57):839-41. PubMed ID: 15143930
[TBL] [Abstract][Full Text] [Related]
25. Serum α1β-glycoprotein and afamin ratio as potential diagnostic and prognostic markers in cholangiocarcinoma.
Tolek A; Wongkham C; Proungvitaya S; Silsirivanit A; Roytrakul S; Khuntikeo N; Wongkham S
Exp Biol Med (Maywood); 2012 Oct; 237(10):1142-9. PubMed ID: 23104505
[TBL] [Abstract][Full Text] [Related]
26. Serum adhesion molecule-1 (ICAM-1) as a potential prognostic marker for cholangiocarcinoma patients.
Janan M; Proungvitaya S; Limpaiboon T; Proungvitaya T; Roytrakul S; Wongkham C; Jearanaikoon P; Chur-in S; Wongkham S
Asian Pac J Cancer Prev; 2012; 13 Suppl():107-14. PubMed ID: 23480771
[TBL] [Abstract][Full Text] [Related]
27. The value of biliary fibronectin for diagnosis of cholangiocarcinoma.
Chen CY; Lin XZ; Tsao HC; Shiesh SC
Hepatogastroenterology; 2003; 50(52):924-7. PubMed ID: 12845951
[TBL] [Abstract][Full Text] [Related]
28. Types and chemical composition of intrahepatic stones.
Suzuki N; Takahashi W; Sato T
Prog Clin Biol Res; 1984; 152():71-80. PubMed ID: 6473392
[TBL] [Abstract][Full Text] [Related]
29. Epidemiological aspects of biliary tree tumors in a region of northern Italy: emerging trends and sex-based differences.
Floreani A; Lisiero M; Baldovin T; Baldo V
Eur J Gastroenterol Hepatol; 2013 Nov; 25(11):1347-51. PubMed ID: 24081106
[TBL] [Abstract][Full Text] [Related]
30. Diagnostic role of serum interleukin 6 and CA 19-9 in patients with cholangiocarcinoma.
Tangkijvanich P; Thong-ngam D; Theamboonlers A; Hanvivatvong O; Kullavanijaya P; Poovorawan Y
Hepatogastroenterology; 2004; 51(55):15-9. PubMed ID: 15011822
[TBL] [Abstract][Full Text] [Related]
31. Malignant perihilar biliary obstruction: magnetic resonance cholangiopancreatographic findings.
Yeh TS; Jan YY; Tseng JH; Chiu CT; Chen TC; Hwang TL; Chen MF
Am J Gastroenterol; 2000 Feb; 95(2):432-40. PubMed ID: 10685746
[TBL] [Abstract][Full Text] [Related]
32. Biochemical epidemiology of gallbladder cancer.
Strom BL; Soloway RD; Rios-Dalenz J; Rodriguez-Martinez HA; West SL; Kinman JL; Crowther RS; Taylor D; Polansky M; Berlin JA
Hepatology; 1996 Jun; 23(6):1402-11. PubMed ID: 8675157
[TBL] [Abstract][Full Text] [Related]
33. Mixed hepatocellular cholangiocarcinoma tumors: Cholangiolocellular carcinoma is a distinct molecular entity.
Moeini A; Sia D; Zhang Z; Camprecios G; Stueck A; Dong H; Montal R; Torrens L; Martinez-Quetglas I; Fiel MI; Hao K; Villanueva A; Thung SN; Schwartz ME; Llovet JM
J Hepatol; 2017 May; 66(5):952-961. PubMed ID: 28126467
[TBL] [Abstract][Full Text] [Related]
34. Serum cathepsin B to cystatin C ratio as a potential marker for the diagnosis of cholangiocarcinoma.
Monsouvanh A; Proungvitaya T; Limpaiboon T; Wongkham C; Wongkham S; Luvira V; Proungvitaya S
Asian Pac J Cancer Prev; 2014; 15(21):9511-5. PubMed ID: 25422248
[TBL] [Abstract][Full Text] [Related]
35. Biliary tract carcinoma complicating primary sclerosing cholangitis: evaluation with CT, cholangiography, US, and MR imaging.
Campbell WL; Ferris JV; Holbert BL; Thaete FL; Baron RL
Radiology; 1998 Apr; 207(1):41-50. PubMed ID: 9530297
[TBL] [Abstract][Full Text] [Related]
36. Marked elevation of serum interleukin-6 in patients with cholangiocarcinoma: validation of utility as a clinical marker.
Goydos JS; Brumfield AM; Frezza E; Booth A; Lotze MT; Carty SE
Ann Surg; 1998 Mar; 227(3):398-404. PubMed ID: 9527063
[TBL] [Abstract][Full Text] [Related]
37. [A case of hepatocellular-cholangiocarcinoma invading the gallbladder].
Namkoong KY; Kang MJ; Im HM; Kim MS; Ko BS; Ahn HT; Lee JR; Kim JO
Korean J Hepatol; 2004 Jun; 10(2):148-53. PubMed ID: 15218349
[TBL] [Abstract][Full Text] [Related]
38. Plasma hydroxyproline, MMP-7 and collagen I as novel predictive risk markers of hepatobiliary disease-associated cholangiocarcinoma.
Prakobwong S; Charoensuk L; Hiraku Y; Pinlaor P; Pairojkul C; Mairiang E; Sithithaworn P; Yongvanit P; Khuntikeo N; Pinlaor S
Int J Cancer; 2012 Aug; 131(4):E416-24. PubMed ID: 21935919
[TBL] [Abstract][Full Text] [Related]
39. Discovery of glycocholic acid and taurochenodeoxycholic acid as phenotypic biomarkers in cholangiocarcinoma.
Song WS; Park HM; Ha JM; Shin SG; Park HG; Kim J; Zhang T; Ahn DH; Kim SM; Yang YH; Jeong JH; Theberge AB; Kim BG; Lee JK; Kim YG
Sci Rep; 2018 Jul; 8(1):11088. PubMed ID: 30038332
[TBL] [Abstract][Full Text] [Related]
40. Biliary bile acid concentration is a simple and reliable indicator for liver function after hepatobiliary resection for biliary cancer.
Kurumiya Y; Nagino M; Nozawa K; Kamiya J; Uesaka K; Sano T; Yoshida S; Nimura Y
Surgery; 2003 May; 133(5):512-20. PubMed ID: 12773979
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
